Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Mach7 Technologies ( (AU:M7T) ).
Mach7 Technologies Limited has announced an update on its ongoing on-market buy-back program, revealing that a total of 4,150,000 ordinary fully paid securities have been repurchased as of May 15, 2025. This strategic move is part of the company’s efforts to optimize its capital structure and potentially enhance shareholder value, reflecting a proactive approach to managing its financial resources.
The most recent analyst rating on (AU:M7T) stock is a Buy with a A$0.95 price target. To see the full list of analyst forecasts on Mach7 Technologies stock, see the AU:M7T Stock Forecast page.
More about Mach7 Technologies
Mach7 Technologies Limited operates in the technology industry, focusing on providing advanced healthcare solutions. The company is known for its innovative software products that enhance medical imaging and data management, catering primarily to healthcare institutions and professionals.
Average Trading Volume: 262,542
Technical Sentiment Signal: Sell
Current Market Cap: A$88.05M
For a thorough assessment of M7T stock, go to TipRanks’ Stock Analysis page.